{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:54:42Z","timestamp":1791928482785,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Scientific Fund","award":["14-50-00069"],"award-info":[{"award-number":["14-50-00069"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bioorg.2017.11.014","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T23:30:34Z","timestamp":1511307034000},"page":"140-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Unprotected primary sulfonamide group facilitates ring-forming cascade en route to polycyclic [1,4]oxazepine-based carbonic anhydrase inhibitors"],"prefix":"10.1016","volume":"76","author":[{"given":"Alexander","family":"Sapegin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kalinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Krasavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2017.11.014_b0005","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2017.11.014_b0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1002143802926","article-title":"The role of carbonic anhydrase inhibitors in the management of macular edema","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.bioorg.2017.11.014_b0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138161208783877866","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2017.11.014_b0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/glia.10187","article-title":"Surface carbonic anhydrase activity on astrocytes and neurons facilitates lactate transport","volume":"41","author":"Svichar","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.bioorg.2017.11.014_b0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2017.11.014_b0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/156802607780636726","article-title":"Carbonic anhydrase inhibitors as anticonvulsant agents","volume":"7","author":"Thiry","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/138161208783877820","article-title":"Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?","volume":"14","author":"Di Fiore","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2017.11.014_b0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2014.991312","article-title":"The \u03b7-class carbonic anhydrases as drug targets for antimalarial agents","volume":"19","author":"Supuran","year":"2015","journal-title":"Expert. Opin. Ther. Targets."},{"key":"10.1016\/j.bioorg.2017.11.014_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin Drug Discov."},{"key":"10.1016\/j.bioorg.2017.11.014_b0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0055","doi-asserted-by":"crossref","first-page":"26233","DOI":"10.1016\/S0021-9258(19)74305-1","article-title":"A New Class of Carbonic Anhydrase Inhibitor","volume":"268","author":"Maren","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-94-007-7359-2_15","article-title":"Carbonic anhydrase inhibitors drug design","volume":"75","author":"McKenna","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0065","doi-asserted-by":"crossref","unstructured":"R.P. Tanpure, B. Ren, T.S. Peat, L.F. Bornaghi, D. Vullo, C.T. Supuran, S.A. Poulsen, Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site, J. Med. Chem. 58 (2015) 1494\u20131501.","DOI":"10.1021\/jm501798g"},{"key":"10.1016\/j.bioorg.2017.11.014_b0070","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/pro.5560071201","article-title":"Structural analysis of inhibitor binding to human carbonic anhydrase II","volume":"7","author":"Boriack-Sjodin","year":"1998","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2017.11.014_b0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.mencom.2008.09.019","article-title":"Synthesis of dibenzo[b, f][1,4]oxazepin-11(10H)-one and pyrido[2,3-b][1,4]benzoxazepin-11(10H)-one compounds based on o-nitrochloro derivatives of benzene and pyridine","volume":"18","author":"Sapegin","year":"2008","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.bioorg.2017.11.014_b0080","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1055\/s-0031-1289789","article-title":"Dibenzo[b, f]pyrazolo[1,5-d][1,4]oxazepines: facile construction of a rare heterocyclic system via tandem aromatic nucleophilic substitution-smiles rearrangement\u2013denitrocyclization","volume":"44","author":"Sapegin","year":"2012","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2017.11.014_b0085","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.tet.2013.12.026","article-title":"New tetracyclic 1,4-oxazepines constructed via practically simple tandem condensation strategy from readily available synthons","volume":"70","author":"Sapegin","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2017.11.014_b0090","article-title":"Efficient use of 1,2-dihaloazine synthons in transition-metal-free preparation of diverse heterocycle-fused 1,4-oxazepines","volume":"1333\u20131340","author":"Sapegin","year":"2015","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0095","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1016\/j.tetlet.2015.08.062","article-title":"Atom-economical construction of tetracyclic [1,4]oxazepines involving intramolecular arylation of a 2-imidazoline moiety","volume":"56","author":"Karamysheva","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2017.11.014_b0100","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1016\/j.tet.2016.10.008","article-title":"A novel, flexible strategy to construct privileged dibenzo[b, f][1,4,5]oxathiazepine 5,5-dioxides and their heterocyclic isosteres","volume":"72","author":"Sapegin","year":"2016","journal-title":"Tetrahedron."},{"key":"10.1016\/j.bioorg.2017.11.014_b0105","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1016\/j.tetlet.2016.11.064","article-title":"Facile entry into structurally diverse, privileged, (hetero)arene-fused N-alkoxy 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-ones","volume":"57","author":"Sapegin","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2017.11.014_b0110","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1039\/C7OB00535K","article-title":"Structurally diverse arene-fused ten-membered lactams accessed via hydrolytic imidazoline ring expansion","volume":"15","author":"Sapegin","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar nature of the carbonic anhydrase active site: Aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14756366.2016.1178248","article-title":"Isoform-selective inhibitory profile of 2-imidazoline-substituted benzenesulfonamides against a panel of human carbonic anhydrases","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0125","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.bmc.2017.02.018","article-title":"Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3-and 4-(hetero)arylisoxazol-5-amine scaffolds","volume":"25","author":"Krasavin","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/14756366.2017.1344236","article-title":"Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases","volume":"32","author":"Krasavin","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0135","first-page":"10930","article-title":"Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases","volume":"154","author":"Bruncko","year":"2010","journal-title":"Chem. Abstr."},{"key":"10.1016\/j.bioorg.2017.11.014_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2725(02)83006-9","article-title":"Aromatic nucleophilic denitrocyclization reactions","volume":"83","author":"Radl","year":"2002","journal-title":"Adv. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0145","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0150","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4155\/fmc.11.69","article-title":"Carbonic anhydrase inhibitors and activators for novel therapeutic applications","volume":"3","author":"Supuran","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0155","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/1087057106289403","article-title":"Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds","volume":"11","author":"Iyer","year":"2006","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bioorg.2017.11.014_b0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20277","article-title":"Functional demonstration of surface carbonic anhydrase IV activity on rat astrocytes","volume":"53","author":"Svichar","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.bioorg.2017.11.014_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/FBP.0b013e328014138d","article-title":"Olanzapine and JL13 induce cross-tolerance to the clozapine discriminative stimulus in rats","volume":"18","author":"Goudie","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bioorg.2017.11.014_b0170","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0960-894X(02)00465-1","article-title":"Construction of a family of biphenyl combinatorial libraries: structure-activity studies utilizing libraries of mixtures","volume":"12","author":"Bhattacharya","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.11.014_b0175","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/00397919008052817","article-title":"A convenient method for the preparation of N-methoxyamides","volume":"20","author":"Einhorn","year":"1990","journal-title":"Synthetic Commun."},{"key":"10.1016\/j.bioorg.2017.11.014_b0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/00397911.2014.974611","article-title":"Lipase-catalyzed solvent-free amidation of phenolic acids","volume":"45","author":"Kaushik","year":"2015","journal-title":"Synthetic Commun."},{"key":"10.1016\/j.bioorg.2017.11.014_b0185","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.bmcl.2013.04.047","article-title":"Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists","volume":"23","author":"Hossain","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.11.014_b0190","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jps.2600581128","article-title":"Ring opening of cyclic salicylamides","volume":"58","author":"Phillips","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2017.11.014_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the \u03b2-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/14756366.2011.621122","article-title":"Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds","volume":"27","author":"Ekinci","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14756366.2011.643303","article-title":"Carbonic anhydrase inhibitors: in vitro inhibition of \u03b1 isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids","volume":"28","author":"Ekinci","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.11.014_b0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/14756366.2012.658788","article-title":"Secondary\/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II","volume":"28","author":"Alp","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817307617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817307617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T21:44:53Z","timestamp":1659908693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206817307617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":42,"alternative-id":["S0045206817307617"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2017.11.014","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unprotected primary sulfonamide group facilitates ring-forming cascade en route to polycyclic [1,4]oxazepine-based carbonic anhydrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2017.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}